Young Adults With Pancreatic Cancer: National Trends in Treatment and Outcomes.

Pancreas
Olatunji B AleseBassel F El-Rayes

Abstract

The treatment and outcomes of patients younger than 50 years (young adults [YAs]) with pancreatic cancer are largely unknown. We evaluated the presentation, treatment, and outcomes of these patients. The National Cancer Database was analyzed. Univariate and multivariate Cox proportional hazards models were performed to identify variables associated with overall survival. A total of 124,442 patients with pancreatic cancer were identified, with 9657 between 18 and 50 years of age. Mean age was 45.4 years (standard deviation, 4.6 years). About 30.9% of YA patients and 25% of patients older than 50 years underwent resection of the primary tumor. Survival advantage was seen for patients 18 to 39 years (hazard ratio, 1.14; 95% confidence interval, 1.07-1.23; P < 0.001). This age advantage was similar across all the racial groups. Overall, YAs treated between 2009 and 2013 had higher survival rates compared with 2004 to 2008 (hazard ratio, 0.85; 95% confidence interval, 0.81-0.89; P < 0.001). This survival improvement was highest in American Indians and Asian/Pacific Islanders (16.6% vs 6.5%), African Americans (10.6% vs 8.5%), and Hispanics (14.5% vs 12.6%). Survival of YAs with pancreatic cancer patients is superior to older patient...Continue Reading

References

Feb 22, 2000·Annals of the New York Academy of Sciences·N E Adler, J M Ostrove
Dec 20, 2002·Cancer·Olufunmilayo I OlopadeCarolyn Whitfield-Broome
Aug 17, 2004·The American Journal of Gastroenterology·Gregory S Cooper, Siran M Koroukian
Mar 21, 2008·Nature Reviews. Cancer·Archie BleyerUNKNOWN Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adul
Nov 26, 2008·Bone Marrow Transplantation·G DiniUNKNOWN EBMT Paediatric Diseases Working Party
Nov 5, 2008·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Avo ArtinyanJoseph Kim
Sep 9, 2010·JAMA : the Journal of the American Medical Association·John P NeoptolemosUNKNOWN European Study Group for Pancreatic Cancer
Jan 17, 2012·Journal of Cancer Research and Clinical Oncology·Vinamrata SingalYong-Fang Kuo
Jul 5, 2012·Journal of Gastrointestinal Cancer·S RaissouniH Errihani
Oct 18, 2013·The New England Journal of Medicine·Daniel D Von HoffMarkus F Renschler
Nov 8, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Aliccia Bollig-FischerGerold Bepler
Apr 15, 2015·Pancreas·Shumaila N KhawjaGeorge Van Buren
May 27, 2015·Nature Reviews. Clinical Oncology·Leonard Sender, Keri B Zabokrtsky
Dec 18, 2016·Seminars in Radiation Oncology·Timothy R Rebbeck
Sep 26, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ReniL Gianni
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
May 29, 2018·American Journal of Surgery·Aitua SalamiAmit R T Joshi
Jul 20, 2018·Cancers·Lisa ScartonDiana J Wilkie
Dec 24, 2018·The New England Journal of Medicine·Thierry ConroyUNKNOWN Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group
Nov 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ReniL Gianni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.